No evidence of the long-term  toxicity of Aeroxide P25 TiO nanoparticles in three mammalian cell lines despite the initial reduction of cellular mitochondrial activity

Sylwia Męczyńska-Wielgosz; Teresa Bartłomiejczyk; Iwona Grądzka; Sylwester Sommer; Aneta Węgierek-Ciuk; Anna Lankoff; Katarzyna Sikorska; Maria Wojewódzka; Małgorzata Dobrzyńska; Marcin Kruszewski

Acceso abierto

No evidence of the long-term in vitro toxicity of Aeroxide P25 TiO₂ nanoparticles in three mammalian cell lines despite the initial reduction of cellular mitochondrial activity

Nukleonika

Volumen 69 (2024): Edición 1 (March 2024)

Acerca de este artículo

Artículo anterior

Artículo siguiente

Cite

Article Category: ORIGINAL PAPER

Publicado en línea: 23 feb 2024

Páginas: 13 - 22

Recibido: 08 mar 2023

Aceptado: 27 nov 2023

DOI: https://doi.org/10.2478/nuka-2024-0002

Palabras clave
γH2AX assay, Caspase 3 activity, Comet assay, Micronucleus assay, MTT assay, Apoptosis

© 2024 Sylwia Męczyńska-Wielgosz et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

SSB and base damage recognized by FPG in A549, HepG2 or HT29 cells treated with Aeroxide P25 TiO2 NP for 2 h (left panel) and 24 h (right panel) at concentrations indicated. Numbers (1, 2) denote results of Tukey’s test post hoc analysis, indicating a significant difference of the means from the control when NP concentration was considered (1) or a significant difference of the means between the same NP concentration, but different treatment times (2).

Mitochondrial activity (MTT assay) of cells treated with Aeroxide P25 TiO2 NP for 24 h and measured 72 h after treatment expressed as a percent of the control (untreated cells). The asterisk denotes a statistically significant difference from the control. Two-way ANOVA with Tukey’s HDS post hoc comparison. P < 0.05.

Short-term survival of cells treated with Aeroxide P25 TiO2 NP for 24 h, as measured by neutral red assay. The asterisk denotes a statistically significant difference from the control. Two-way ANOVA with Tukey’s HDS post hoc comparison. P < 0.05.

Cloning ability determination of A549, HT29 and HepG2 cells growing in the presence of Aeroxide P25 TiO2 NP.

Generation of ROS in HepG2, A549 and HT29 cells incubated with Aeroxide P25 TiO2 NP. H2O2 in a concentration of 1 mM served as a positive control. The data provided are in the form mean ± SD. n denotes the number of experiments; n = 3. The asterisk denotes statistically significant difference from unexposed control, P < 0.05.

Frequency of micronuclei and mean number of γ-H2AX foci per nucleus after 2 h and 24 h treatment with TiO2 NP concentrations indicated, and with the effect of X-irradiation with 2 Gy shown for comparison

Micronuclei frequency
Treatment	Dose	Cell line/time of treatment
		A549		HepG2		HT29
		2 h	24 h	2 h	24 h	2 h	24 h
Control		22.9 ± 9.5	31.5 ± 2.0	34.6 ± 3.4	26.3 ± 7.8	5.9 ± 3.2	7.5 ± 1.8
X-ray	2 Gy	80.1 ± 5.2^a		155.2 ± 7.7^a		45.5 ±0.3^a
TiO₂ NP 21 nm	10 μg/mL	33.2 ± 6.9	26.8 ± 7.5	22.3 ± 8.8	27.0 ± 9.5	6.8 ± 1.0	8.5 ± 6.6
	50 μg/mL	22.5 ± 9.6	25.2 ± 3.7	24.6 ± 4.5	23.0 ± 4.4	5.5 ± 0.9	7.8 ± 1.6
	100 μg/mL	25.5 ± 5.8	30.0 ± 8.2	24.5 ± 12.5	23.5 ± 6.4	6.1 ± 2.8	10.0 ± 7.2
The mean number of γ-H2AX foci per nucleus
Treatment	Dose	Cell line/time of treatment
		A549		HepG2		HT29
		2 h	24 h	2 h	24 h	2 h	24 h
Control		10.8 ± 5.7	10.7 ± 3.0	23.6 ± 10.8	7.2 ± 2.1	25.5 ± 10.1	26.4 ± 10.1
X-ray	2 Gy	78.2 ± 10.2^a		87.2 ± 10.0”		87.9 ± 3.4^a
TiO₂ NP 21 nm	10 μg/mL	11.2 ± 6.8	10.5 ± 3.1	21.1 ± 6.0	9.7 ± 4.0	25.4 ± 10.0	25.0 ± 9.4
	50 μg/mL	10.3 ± 3.5	7.8 ± 1.5	19.3 ± 5.6	11.4 ± 2.7	26.6 ± 6.8	23.7 ± 8.8
	100 μg/mL	10.6 ± 4.1	6.4 ± 2.5	18.3 ± 8.0	9.5 ± 3.2	28.0 ± 5.0	24.5 ± 10.5

The extent of apoptosis after 2 h and 24 h treatment with TiO2 NP at indicated concentrations

Treatment	Dose	Cell line/time of treatment
		A549		HepG2		HT29
		2h	24 h	2h	24 h	2h	24 h
Control	Viable	99.16 ± 0.14	98.36 ± 0.16	97.63 ± 0.29	96.34 ± 0.43	98.03 ± 0.55	97.04 ± 0.69
	Early apoptosis	0.54 ± 0.21	1.34 ± 0.26	2.20 ± 0.30	3.22 ± 0.29	1.80 ± 0.56	2.61 ± 0-43
	Late apoptosis and necrosis	0.30 ± 0.10	0.30 ± 0.08	0.17 ± 0.15	0.44 ± 0.17	0.17 ± 0.06	0.35 ± 0.09
Staurosporine/24 h^b	Viable	32.48 ± 8.88^a		23.70 ± 5.33^a		20.20 ± 3.20^a
	Early apoptosis	7.98 ± 2.33^a		48.20 ± 3.22^a		58.03 ± 4.98^a
	Late apoptosis and necrosis	59.54 ± 3.99^a		28.10 ± 2.56^a		21.77 ± 2.37^a
TiO₂ NP 10 mg/mL	Viable	93.07 ± 0.81^a	93.30 ± 1.20^a	93.20 ± 0.26^a	92.93 ± 0.64^a	93.13 ± 0.25^a	92.50 ± 1.46^a
	Early apoptosis	5.10 ± 0.44^a	4.70 ± 0.75^a	5.03 ± 1.03	4.53 ± 0.40^a	4.43 ± 0.75	4.17 ± 0.79
	Late apoptosis and necrosis	1.83 ± 0.40^a	2.00 ± 0.46^a	1.77 ± 0.81	2.53 ± 0.26^a	2.43 ± 0.50^a	3.33 ± 0.81^a
TiO₂ NP 50 mg/mL	Viable	92.10 ± 0.80^a	93.93 ± 1.75^a	93.97 ± 0.65^a	91.13 ± 1.37^a	93.17 ± 0.78^a	91.83 ± 1.60^a
	Early apoptosis	5.97 ± 0.76^a	3.83 ± 1.33^a	3.97 ± 0.61	6.00 ± 1.15^a	3.70 ± 0.60	5.17 ± 1.40^a
	Late apoptosis and necrosis	1.93 ± 0.15^a	2.23 ±0.42^a	2.07 ±0.15^a	2.87 ± 0.35^a	3.13 ±0.25^a	3.00 ± 0.26^a
TiO₂NP 100 mg/mL	Viable	93.63 ± 1.20^a	91.87 ± 1.10^a	93.73 ± 0.64^a	90.87 ± 0.96^a	92.23 ± 1.46^a	90.57 ± 0.23^a
	Early apoptosis	3.97 ± 0.75^a	5.90 ± 1.47^a	4.27 ± 0.40^a	6.33 ± 0.91^a	4.70 ± 0.79^a	6.17 ± 0.65^a
	Late apoptosis and necrosis	2.40 ± 0.46^a	2.23 ± 0.40^a	2.00 ± 0.26^a	2.80 ± 0.26^a	3.07 ± 0.81^a	3.27 ± 0.47^a

Caspase 3 activity after 2 h and 24 h treatment with TiO2 NP at indicated concentrations

Treatment	Cell line/time of treatment
	A549		HepG2		HT29
	2 h	24 h	2 h	24 h	2 h	24 h
Control	0.12 ±0.05	0.05 ±0.01	1.02 ±0.03	1.42 ±0.02	0.26 ±0.02	0.42 ±0.03
TiO₂ NP 10 mg/mL	0.10 ± 0.02	0.06 ± 0.01	0.98 ± 0.02	1.43 ± 0.09	0.31 ± 0.01	0.41 ± 0.06
TiO₂ NP 50 mg/mL	0.13 ± 0.02	0.07 ± 0.01	1.08 ± 0.07	1.37 ± 0.05	0.51 ± 0.05^a	0.63 ±0.05^a
TiO₂ NP 100 mg/mL	0.11 ± 0.01	0.07 ± 0.01	1.39 ± 0.06^a	1.39 ± 0.03	0.37 ± 0.02^a	0.55 ± 0.04^a
Positive control: Jurkat cells treated with 1 mM staurosporine for 24 h : 39.89 ± 3.82^a

Hydrodynamic diameter and zeta potential of Aeroxide P25 TiO2 NPs in water, EMEM, F12 and DMEM media

Medium	Hydrodynamic diameter (nm)	Polydispersity index (PDI)	Zeta potential 7.4 (mV)
Water	356 ± 1	0.457 ± 0.04	–15.3 ± 0.5
EMEM	246 ± 1	0.193 ± 0.07	–25.5 ± 0.6
F12	295 ± 3	0.220 ± 0.05	–28.7 ± 2.5
DMEM	300 ± 2	0.280 ± 0.07	–27.5 ± 0.2

eISSN:: 1508-5791
Idioma:: Inglés

Calendario de la edición:: 4 veces al año
Temas de la revista:: Chemistry, Nuclear Chemistry, Physics, Astronomy and Astrophysics, other

RSS Feed de revista

No evidence of the long-term in vitro toxicity of Aeroxide P25 TiO₂ nanoparticles in three mammalian cell lines despite the initial reduction of cellular mitochondrial activity

Article Category: ORIGINAL PAPER

Publicado en línea: 23 feb 2024

Páginas: 13 - 22

Recibido: 08 mar 2023

Aceptado: 27 nov 2023

DOI: https://doi.org/10.2478/nuka-2024-0002

Palabras clave
γH2AX assay, Caspase 3 activity, Comet assay, Micronucleus assay, MTT assay, Apoptosis

© 2024 Sylwia Męczyńska-Wielgosz et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Frequency of micronuclei and mean number of γ-H2AX foci per nucleus after 2 h and 24 h treatment with TiO2 NP concentrations indicated, and with the effect of X-irradiation with 2 Gy shown for comparison

The extent of apoptosis after 2 h and 24 h treatment with TiO2 NP at indicated concentrations

Caspase 3 activity after 2 h and 24 h treatment with TiO2 NP at indicated concentrations

Hydrodynamic diameter and zeta potential of Aeroxide P25 TiO2 NPs in water, EMEM, F12 and DMEM media

No evidence of the long-term in vitro toxicity of Aeroxide P25 TiO2 nanoparticles in three mammalian cell lines despite the initial reduction of cellular mitochondrial activity

Article Category: ORIGINAL PAPER

Publicado en línea: 23 feb 2024

Páginas: 13 - 22

Recibido: 08 mar 2023

Aceptado: 27 nov 2023

DOI: https://doi.org/10.2478/nuka-2024-0002

Palabras claveγH2AX assay, Caspase 3 activity, Comet assay, Micronucleus assay, MTT assay, Apoptosis

© 2024 Sylwia Męczyńska-Wielgosz et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Fig. 1.

Fig. 2.

Fig. 3.

Fig. 4.

Fig. 5.

Frequency of micronuclei and mean number of γ-H2AX foci per nucleus after 2 h and 24 h treatment with TiO2 NP concentrations indicated, and with the effect of X-irradiation with 2 Gy shown for comparison

The extent of apoptosis after 2 h and 24 h treatment with TiO2 NP at indicated concentrations

Caspase 3 activity after 2 h and 24 h treatment with TiO2 NP at indicated concentrations

Hydrodynamic diameter and zeta potential of Aeroxide P25 TiO2 NPs in water, EMEM, F12 and DMEM media

No evidence of the long-term in vitro toxicity of Aeroxide P25 TiO₂ nanoparticles in three mammalian cell lines despite the initial reduction of cellular mitochondrial activity

Palabras clave
γH2AX assay, Caspase 3 activity, Comet assay, Micronucleus assay, MTT assay, Apoptosis